Treatment with infliximab is associated with "Major clinical response" in psoriatic arthritis patients treated with infliximab: Analysis of two double-blind placebo controlled trials.

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/2124

Title:	Treatment with infliximab is associated with "Major clinical response" in psoriatic arthritis patients treated with infliximab: Analysis of two double-blind placebo controlled trials.
Authors:	Kavanaugh, A Krueger, GG Birbara, C Halter, D de Vlam, K Zhou, B Dooley, L Guzzo, C Bala, M. Beutler, A Antoni, C. GEUSENS, Piet
Issue Date:	2005
Publisher:	WILEY-LISS
Source:	ARTHRITIS AND RHEUMATISM, 52(12). p. 4065-4065
Notes:	Univ Calif San Diego, La Jolla, CA 92093 USA. Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA. Univ Massachusetts, Sch Med, Worcester, MA USA. Houston Inst Clin Res, Houston, TX USA. Limburgs Univ Ctr, Diepenbeek, Belgium. Univ Hosp, Maastricht, Netherlands. Univ Hosp Leuven, Louvain, Belgium. Centocor Inc, Malvern, PA USA. Univ Erlangen Nurnberg, Erlangen, Germany.
Document URI:	http://hdl.handle.net/1942/2124
ISSN:	0004-3591
ISI #:	000234131500080
Category:	M
Type:	Journal Contribution
Appears in Collections:	Research publications

3

checked on Apr 16, 2024

22

checked on Oct 30, 2023

Check